Ovarian Cancer Treatments Strategy: Focus on PARP Inhibitors and Immune Check Point Inhibitors

SIMPLE SUMMARY: Ovarian cancer treatment is the deadliest of gynecological cancers but the introduction of target therapies in its therapeutic algorithm has significantly improved outcomes. The aim of this article was to provide a review of completed and ongoing clinical trials involving the use of...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancers (Basel)
Main Authors: Nero, Camilla, Ciccarone, Francesca, Pietragalla, Antonella, Duranti, Simona, Daniele, Gennaro, Salutari, Vanda, Carbone, Maria Vittoria, Scambia, Giovanni, Lorusso, Domenica
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7999042/
https://ncbi.nlm.nih.gov/pubmed/33803954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13061298
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki